Max Planck Institute for Infection Biology
Stefan H. E. Kaufmann, PhD, is founding director of the Max Planck Institute for Infection Biology, Berlin, Germany, where he heads the Department of Immunology. He is also Professor for Microbiology and Immunology at the Charité, Berlin, Doctor Honoris Causa from Marseille University, France and Faculty Fellow of the Hagler Institute for Advanced Study, Texas A&M University, USA. He is former President of the German Society for Immunology, the European Federation of Immunological Societies, and the International Union of Immunological Societies. He is interested in immunity to tuberculosis (TB) and rational vaccine and biomarker design. He developed a recombinant TB vaccine candidate which has reached phase III clinical trial and designed a prognostic biosignature to predict TB. Kaufmann is former member of the Scientific Advisory Boards of TB-Alliance, GAVI and EDCTP. He published >900 papers with > 60.000 citations with an h-factor of 130 (Google Scholar). He received numerous awards, is member of several professional academies including American Academy of Microbiology, Berlin–Brandenburg Academy of Sciences and Humanities, German National Academy of Sciences Leopoldina, and European Molecular Biology Organization (EMBO).